71 related articles for article (PubMed ID: 3262726)
1. Biodistribution and radiation dosimetry of radioiodinated-SCH 23982, a potential dopamine D-1 receptor imaging agent.
Thonoor CM; Couch MW; Greer DM; Thomas KD; Williams CM
J Nucl Med; 1988 Oct; 29(10):1668-74. PubMed ID: 3262726
[TBL] [Abstract][Full Text] [Related]
2. Radiation dosimetry of iodine-123 HEAT, an alpha-1 receptor imaging agent.
Thomas KD; Greer DM; Couch MW; Williams CM
J Nucl Med; 1987 Nov; 28(11):1745-50. PubMed ID: 2822868
[TBL] [Abstract][Full Text] [Related]
3. Preparation and biodistribution of [125I]IBZP: a potential CNS D-1 dopamine receptor imaging agent.
Kung HF; Billings JJ; Guo YZ; Blau M; Ackerhalt R
Int J Rad Appl Instrum B; 1988; 15(2):187-93. PubMed ID: 2966781
[TBL] [Abstract][Full Text] [Related]
4. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
Kung HF; Alavi A; Chang W; Kung MP; Keyes JW; Velchik MG; Billings J; Pan S; Noto R; Rausch
J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Kung HF; Pan S; Kung MP; Billings J; Kasliwal R; Reilley J; Alavi A
J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
[TBL] [Abstract][Full Text] [Related]
6. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
[TBL] [Abstract][Full Text] [Related]
8. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.
Seibyl JP; Wallace E; Smith EO; Stabin M; Baldwin RM; Zoghbi S; Zea-Ponce Y; Gao Y; Zhang WY; Neumeyer JL
J Nucl Med; 1994 May; 35(5):764-70. PubMed ID: 8176456
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging.
Moerlein SM; Parkinson D; Welch MJ
Int J Rad Appl Instrum A; 1990; 41(4):381-5. PubMed ID: 2158956
[TBL] [Abstract][Full Text] [Related]
10. The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor.
Mozley PD; Zhu X; Kung HF; Selikson MH; Hickey J; Galloway S; Pfieffer N; Alavi A
J Nucl Med; 1993 Feb; 34(2):208-13. PubMed ID: 8429338
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation of (+)-2- [123I]A-69024: a radioligand for in vivo studies of dopamine D1 receptors.
Kassiou M; Mardon K; Mattner F; Katsifis A; Dikic B
Life Sci; 2001 Jun; 69(6):669-75. PubMed ID: 11476188
[TBL] [Abstract][Full Text] [Related]
12. [125I](+/-)FISCH: a new CNS D-1 dopamine receptor imaging ligand.
Billings J; Kung MP; Chumpradit S; Pan S; Kung HF
Life Sci; 1989; 45(8):711-8. PubMed ID: 2779358
[TBL] [Abstract][Full Text] [Related]
13. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
Kung MP; Kung HF; Billings J; Yang Y; Murphy RA; Alavi A
J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
[TBL] [Abstract][Full Text] [Related]
14. 123I-SCH 23982 is not suitable for dopamine D1 receptor imaging in vivo in the human brain.
Verhoeff NP; Bekier A; Beer HF; Schubiger PA; Fennema P; van Royen EA
Nucl Med Commun; 1993 Feb; 14(2):137-44. PubMed ID: 8429993
[TBL] [Abstract][Full Text] [Related]
15. Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortex.
Hughes A; Sever P
Biochem Pharmacol; 1989 Mar; 38(5):781-5. PubMed ID: 2522780
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Kung HF; Guo YZ; Billings J; Xu X; Mach RH; Blau M; Ackerhalt RE
Int J Rad Appl Instrum B; 1988; 15(2):195-201. PubMed ID: 2966782
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.
Votaw JR; Ansari MS; Mason NS; Schmidt D; de Paulis T; Holburn G; Clanton JA; Votaw DB; Manning RG; Kessler RM
J Nucl Med; 1995 Jul; 36(7):1316-21. PubMed ID: 7790962
[TBL] [Abstract][Full Text] [Related]
18. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
Boundy KL; Barnden LR; Rowe CC; Reid M; Kassiou M; Katsifis AG; Lambrecht RM
J Nucl Med; 1995 Jul; 36(7):1332-8. PubMed ID: 7790964
[TBL] [Abstract][Full Text] [Related]
19. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
Monsma FJ; Sibley DR
Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo testing of the dopamine D1 ligand [123I]SCH 23982 with respect to its potential application in SPET investigations.
Beer HF; Lin S; Bläuenstein P; Hasler P; Schubiger PA; Maier A; Lichtensteiger W; Oettli R; Bekier A; Weder B
Nucl Med Biol; 1993 Jul; 20(5):607-16. PubMed ID: 8358346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
